☆ 4.4 Editorial Material

Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Get Full Text
Add to Collection

Journal

DIABETES TECHNOLOGY & THERAPEUTICS
Volume 20, Issue 9, Pages 571-575

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2018.0246

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Abbott
  2. AstraZeneca
  3. Bayer
  4. Boehringer
  5. DexCom
  6. Insulet Corp.
  7. Eli Lilly
  8. Medtronic
  9. NovoNordisk
  10. Roche
  11. Sanofi

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.